SNAI2 and cancer: While the mesenchymal signal in simulated bulk expression profiles predominantly reflects the presence of CAFs, our analysis also identifies specific ESGs (e.g. SNAI2, SDC1/4 and LAMC2) whose expression levels in the cancer cells are higher than or comparable to those in CAFs (Fig. 1b).